UBS Group’s Labcorp LH Stock Holding History

UBS Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,100	Closed	-$3.07M	–	9822
2024 Q2	$3.07M	Buy	15,100 +100	+0.7%	+$20.3K	﹤0.01%	3323
2024 Q1	$3.28M	Hold	15,000	–	–	﹤0.01%	3421
2023 Q4	$3.41M	Hold	15,000	–	–	﹤0.01%	3192
2023 Q3	$3.02M	Sell	15,000 -17,592	-54%	-$3.71M	﹤0.01%	3051
2023 Q2	$6.76M	Hold	32,592	–	–	﹤0.01%	2296
2023 Q1	$6.42M	Hold	32,592	–	–	﹤0.01%	2283
2022 Q4	$6.59M	Hold	32,592	–	–	﹤0.01%	2237
2022 Q3	$5.74M	Buy	+32,592	New	+$6.67M	﹤0.01%	2238
2019 Q4	–	Sell	-15,132	Closed	-$2.18M	–	8284
2019 Q3	$2.18M	Sell	15,132 -62,507	-81%	-$9.12M	﹤0.01%	3200
2019 Q2	$11.5M	Buy	+77,639	New	+$10.8M	﹤0.01%	1635
2018 Q4	–	Sell	-23,280	Closed	-$3.47M	–	8175
2018 Q3	$3.47M	Sell	23,280 -28,402	-55%	-$4.32M	﹤0.01%	2694
2018 Q2	$7.97M	Buy	+51,682	New	+$7.8M	﹤0.01%	1931
2017 Q3	–	Sell	-8,730	Closed	-$1.16M	–	7874
2017 Q2	$1.16M	Buy	+8,730	New	+$1.07M	﹤0.01%	3491
2016 Q4	–	Sell	-45,396	Closed	-$5.36M	–	7909
2016 Q3	$5.36M	Buy	+45,396	New	+$5.35M	﹤0.01%	1957

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group's LH Position: Q1 2026 in Review

UBS Group increased its Labcorp (LH) stake by 14% in Q1 2026, buying an estimated $18.7M and bringing the position to 564,529 shares worth $151M. The position accounts for 0.02% of the portfolio, ranked #768.

UBS Group first reported a position in LH in Q4 2014 and has held it in 46 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

UBS Group held 564,529 shares of Labcorp worth $151M as of Q1 2026.
UBS Group bought 68,994 Labcorp shares in Q1 2026, an estimated $18.7M.
Labcorp made up 0.02% of UBS Group's portfolio in Q1 2026, its #768 holding.
UBS Group first reported a position in Labcorp in Q4 2014 and has held it in 46 quarters since.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.